Does race predict the development of metastases in men who receive androgen ‐deprivation therapy for a biochemical recurrence after radical prostatectomy?

ConclusionsAmong veterans who received ADT post ‐BCR after RP, race was not a predictor of metastases or other adverse outcomes. The current findings suggest that research efforts to understand racial differences in prostate cancer biology should focus on early stages of the disease (ie, closer to the time of diagnosis).

Source: Cancer - November 14, 2018 Category: Cancer & Oncology Authors: Adriana C. Vidal, Lauren E. Howard, Amanda De Hoedt, Christopher J. Kane, Martha K. Terris, William J. Aronson, Matthew R. Cooperberg, Christopher L. Amling, Stanislav Lechpammer, Scott C. Flanders, Stephen J. Freedland Tags: Original Article Source Type: research